March 18 (Friday)
Symposium 1: Where Will Artificial Intelligence Lead Human Beings?
| Date & Time | March 18 (Friday), 09:00 - 10:20 | |
|---|---|---|
| Chairs | Moon Kyung Joo (Korea University, Korea) Yuichi Mori (Showa University, Japan) |
|
| Speakers | 09:00 - 09:20 | Artificial intelligence endoscopy: How far? And Where to?
Yuichi Mori (Showa University, Japan) |
| 09:20 - 09:40 | Challenges and opportunities of digital pathology Kyu-Hwan Jung (VUNO, Korea) |
|
| 09:40 - 10:00 | Artificial intelligence and data-driven precision medicine in gastric cancer Tae Hyun Hwang (Mayo Clinic, USA) |
|
| 10:00 - 10:20 | Lessons from artificial intelligence: Gastroenterologist's perspective Chang Seok Bang (Hallym University, Korea) |
|
Symposium 2. Bright and Dark Sides of Acid Suppressants: Dispute and Truth
| Date & Time | March 18 (Friday), 10:40 - 12:00 | |
|---|---|---|
| Chairs | Jae J. Kim (Sungkyunkwan University, Korea) Takahisa Furuta (Hamamatsu University, Japan) |
|
| Speakers | 10:40-11:00 | Long-term PPI therapy and risk of gastrointestinal cancer Seung In Seo (Hallym University, Korea) |
| 11:00-11:20 | Long-term risks and complications of P-CAB intake Takahisa Furuta (Hamamatsu University, Japan) |
|
| 11:20-11:40 | PPI use and duodenal inflammation in functional dyspepsia Lucas Wauters (University Hospitals Leuven, Belgium) |
|
| 11:40-12:00 | Acid suppression and clinical outcomes in COVID-19: PPI vs. famotidine In Kyung Yoo (CHA University, Korea) |
|
Symposium 3. Exploring Microbiome in Gastrointestinal Diseases
| Date & Time | March 18 (Friday), 13:00 - 14:20 | |
|---|---|---|
| Chairs | Yong Chan Lee (Yonsei University, Korea) Nadeem O. Kaakoush (University of New South Wales, Australia) |
|
| Speakers | 13:00 - 13:20 | Salivary microbiome: Is it connected to gastrointestinal disease? Yoshihisa Yamashita (Kyushu University, Japan) |
| 13:20 - 13:40 | Esophageal microbiome in GERD and metaplasia: A key player or innocent bystander? Nadeem O. Kaakoush (University of New South Wales, Australia) |
|
| 13:40 - 14:00 | A long journey of the gastric microbiome: Aging and H. pylori eradication Cheol Min Shin (Seoul National University, Korea) |
|
| 14:00 - 14:20 | Live biotherapeutic products in the treatment of human cancer Hansoo Park (Gwangju Institute of Science and Technology (GIST), Korea) |
|
Symposium 4. Asian Topic Forum: Current Use of Acid Suppressants (PPI, P-CAB, and H2 blocker)
| Date & Time | March 18 (Friday), 15:20 - 16:50 | |
|---|---|---|
| Chairs | Jae Gyu Kim (Chung-Ang University, Korea) Varocha Mahachai (Thammasat University, Thailand) |
|
| Speakers | 15:20 -15:30 | Current use of acid suppressants in Thailand Varocha Mahachai (Thammasat University, Thailand) |
| 15:30 - 15:40 | Current use of acid suppressants in Myanmar Than Than Aye (University of Medicine 1 Yangon, Myanmar) |
|
| 15:40-15:50 | Current use of acid suppressants in Singapore Tiing Leong Ang (Changi General Hospital, Singapore) |
|
| 15:50 - 16:00 | Current use of acid suppressants in Philippines Jose D. Sollano (University of Santo Tomas, Philippines) |
|
| 16:00 - 16:10 | Current use of acid suppressants in Vietnam Vu Van Khien (108 Military Central Hospital, Vietnam) |
|
| 16:10 - 16:20 | Current use of acid suppressants in Malaysia Alex Hwong Ruey Leow (University of Malaya, Malaysia) |
|
| 16:20 - 16:30 | Current use of acid suppressants in Mongolia Sarantuya Gidaagaya (Intermed Hospital, Mongolia) |
|
| 16:30 - 16:40 | Current use of acid suppressants in Indonesia Marcellus Simadibrata (University of Indonesia, Indonesia) |
|
| 16:40 - 16:50 | Discussion | |
March 19 (Saturday)
Symposium 5: PUD: Diagnosis, Prevention, Complications, and More
| Date & Time | March 19 (Saturday), 11:10 - 12:30 | |
|---|---|---|
| Chairs | Nayoung Kim (Seoul National University, Korea) Joseph Sung (Nanyang Technology University, Singapore) |
|
| Speakers | 11:10 - 11:30 | Pathophysiology and risk factors in PUD Joseph Sung (Nanyang Technology University, Singapore) |
| 11:30 - 11:50 | Diagnostic and medical treatment approaches for idiopathic/refractory PUD Takeshi Kanno (Tohoku University, Japan) |
|
| 11:50 - 12:10 | Prevention and treatment strategy of PUD associated with aspirin and antiplatelet agent Joon Sung Kim (The Catholic University of Korea, Korea) |
|
| 12:10 - 12:30 | Endoscopic treatment of complications of PUD Da Hyun Jung (Yonsei University, Korea) |
|
Symposium 6: Optimized Diagnosis and Management for H. pylori and Recent Update of H. pylori Registry
| Date & Time | March 19 (Saturday), 15:40 - 17:00 | |
|---|---|---|
| Chairs | Hwoon-Yong Jung (University of Ulsan, Korea) Javier P. Gisbert (Universidad Autónoma de Madrid, Spain) |
|
| Speakers | 15:40 - 16:00 | When and how to test antibiotic resistance before H. pylori eradication in USA? Shailja C. Shah (University of California San Diego, USA) |
| 16:00 -16:20 | When and how to test antibiotic resistance before H. pylori eradication in Japan? Sho Suzuki (Nihon University, Japan) |
|
| 16:20 - 16:40 | The results and further plans of European H. pylori registry Javier P. Gisbert (Hospital Universitario de La Princesa, Spain) |
|
| 16:40- 17:00 | The interim results and things to consider of the Korean H. pylori registry Hyo-Joon Yang (Sungkyunkwan University, Korea) |
|
March 19 (Saturday)
Free Paper 1
| Date & Time | March 19 (Saturday), 08:50 - 09:30 (Room A) | |
|---|---|---|
| Chairs | Sung Soo Kim (The Catholic University of Korea, Korea) Jun Haeng Lee (Sungkyunkwan University, Korea) |
|
| Speakers | 08:50 - 09:00 | Efficacy of Helicobacter pylori treatment in Vietnam over 10 years from 2011 to 2021 Doan Nguyen (University of Pharmacy and Medicine, Vietnam) |
| 09:00 - 09:10 | Vonoprazan based triple and high dose dual therapies are effective in the primary eradication of H. pylori infection - An interim analysis Khoo Stanley (University of Malaya, Malaysia) |
|
| 09:10 - 09:20 | Effect of prior dosage of azithromycin on Helicobacter pylori eradication therapy Se in Hah (Gyeongsang National University, Korea) |
|
| 09:20 - 09:30 | A polygenic risk score of Helicobacter pylori for risk prediction of gastric cancer Xiaoyu Wang (Qingdao University, China) |
|
Free Paper 2
| Date & Time | March 19 (Saturday), 08:50 - 09:30 (Room B) | |
|---|---|---|
| Chairs | Joo Young Cho (CHA University, Korea) Su Jin Hong (Soonchunhyang University, Korea) |
|
| Speakers | 08:50 - 09:00 | Deep-learning for the diagnosis of esophageal cancers and precursor lesions in endoscopic images: A model establishment and nationwide multicenter performance verification study Eun Jeong Gong (University of Ulsan, Korea) |
| 09:00 - 09:10 | Tumor budding is important to predict the risk of lymph node metastasis in early gastric cancer Yeonjin Je (Yonsei University, Korea) |
|
| 09:10 - 09:20 | Nomogram for pre-procedural prediction of non-curative endoscopic resection in early gastric cancer patients So Young Han (Yonsei University, Korea) |
|
| 09:20 - 09:30 | Antibiotics resistance of Helicobacter pylori and treatment outcome of peptic ulcer in Vietnamese children Thi Viet Ha Nguyen (Hanoi Medical University, Vietnam) |
|
Free Paper 3
| Date & Time | March 19 (Saturday), 09:30 - 10:10 (Room A) | |
|---|---|---|
| Chairs | Hyun Yong Jeong (Chungnam National University, Korea) Ki-Nam Shim (Ewha Womans University, Korea) |
|
| Speakers | 09:30 - 09:40 | Comparison of the efficacies of standard triple, sequential and quadruple antibiotic therapy in eradicating Helicobacter pylori infection: A randomized controlled trial Mohd Imran Chouhan (All India Institute of Medical Sciences, India) |
| 09:40 - 09:50 | The Efficacy of 10 days of tegoprazan based non-bismuth containing quadruple therapies on the first-line Helicobacter pylori eradication Yong Hwan Kwon (Kyungpook National University, Korea) |
|
| 09:50 - 10:00 | Factors associated with successful eradication in patients with multiple Helicobacter pylori treatment failures: A population-based study Natsuda Aumpan (Thammasat University, Thailand) |
|
| 10:00 - 10:10 | Zinc Carnosine-based modified bismuth quadruple therapy versus standard triple therapy for Helicobacter pylori eradication: A prospective open-label randomized study Ali Choukair (Clemenceau Medical Center, United Arab Emirates) |
|
Free Paper 4
| Date & Time | March 19 (Saturday), 09:30 - 10:10 (Room B) | |
|---|---|---|
| Chairs | Ok-Jae Lee (Gyeongsang National University, Korea) Suck Chei Choi (Wonkwang University, Korea) |
|
| Speakers | 09:30 - 09:40 | Helicobacter pylori isolates from Mongolia describing gastric carcinogenesis and human migration Boldbaatar Gantuya (Mongolian National University, Mongolia) |
| 09:40 - 09:50 | Histamine-2 receptor antagonists and proton pump inhibitors are associated with decreased incidence of COVID-19 in patients without comorbidities including diabetes, hypertension, and dyslipidemia: A propensity score-matched nationwide cohort study Bokyung Kim (Seoul National University, Korea) |
|
| 09:50 - 10:00 | Changes in the proportion of gastrointestinal emergency endoscopy and peptic ulcer disease during the COVID-19 pandemic: A local retrospective observational study from Vietnam Hang Dao (Hanoi Medical University, Vietnam) |
|
| 10:00 - 10:10 | High dose local-made oral omeprazole versus standard continuous intravenous pantoprazole in patient with peptic ulcer bleeding underwent successful therapeutic endoscopy; Non-inferiority randomized trial: A preliminary result Kanteera Sriyudthsak (Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thailand) |
|
Free Paper 5
| Date & Time | March 19 (Saturday), 10:10 - 10:50 (Room A) | |
|---|---|---|
| Chairs | Jeong Seop Moon (Inje University, Korea) Gwang Ho Baik (Hallym University, Korea) |
|
| Speakers | 10:10 - 10:20 | Efficacy of a novel PCR method (Allplex™ H.pylori & ClariR Assay) for Helicobacter pylori eradication Ilsoo Kim (The Catholic University of Korea, Korea) |
| 10:20 - 10:30 | Real-time polymerase chain reaction for detection of Helicobacter pylori and clarithromycin resistance Jin Hee Noh (University of Ulsan, Korea) |
|
| 10:30 - 10:40 | Time-trend and endoscopic-pathological characteristics of early-onset gastric carcinoma in Vietnamese: A single-hospital experience Lan Tran Thi Ngoc (An Binh Hospital, Vietnam) |
|
| 10:40 - 10:50 | Gastric cancer in elderly patients Yonghoon Choi (Seoul National University, Korea) |
|
Free Paper 6
| Date & Time | March 19 (Saturday), 10:10 - 10:50 (Room B) | |
|---|---|---|
| Chairs | Kwang Jae Lee (Ajou University, Korea) Moo In Park (Kosin University, Korea) |
|
| Speakers | 10:10 - 10:20 | Altered gastric microbiota and inflammatory cytokine responses in patients with Helicobacter pylori-negative gastric dysplasia and cancer Hyo-Joon Yang (Sungkyunkwan University, Korea) |
| 10:20 - 10:30 | Dysbiotic change in gastric microbiome and its functional implication in gastric carcinogenesis Jae Yong Park (Chung-Ang University, Korea) |
|
| 10:30 - 10:40 | Symptom response in patients with functional dyspepsia after rifaximin treatment Nang Khin Phone Tint (Yangon General Hospital, Myanmar) |
|
| 10:40 - 10:50 | MicroRNA expression in plasma of esophageal squamous cell carcinoma patients Dong Chan Joo (Pusan National University, Korea) |
|
Plenary Session
| Date & Time | March 19 (Saturday), 14:20 - 15:20 | |
|---|---|---|
| Chairs | Soo-Heon Park (The Catholic University of Korea, Korea) Sung Kook Kim (Kyungpook National University, Korea) |
|
| Speakers | 14:20 - 14:35 | Eradication rates and cost analysis between the empirical concomitant and tailored therapy based on 23S rRNA point mutation: A multicenter randomized controlled trial Sujin Kim (Pusan National University, Korea) |
| 14:35 - 14:50 | The proportion of mixed carcinoma and its effect on the prognosis of 7,215 patients with gastric cancer Hyeong Ho Jo (Seoul National University, Korea) |
|
| 14:50 - 15:05 | Idenification of exosomal lncRNA, Linc00853 involved in gastric cancer development and carcinogenic mechanism through PDZK1-AKT-MAP17 pathway Hyo Joo Byun (Yonsei University, Korea) |
|
| 15:05 - 15:20 | Immune microarchitectural changes in regional lymph nodes after chemotherapy in oesophageal cancer - results from the UK MRC OE02 trial Maximilian Kloft (Maastricht University Medical Centre, Nertherlands) |
|
March 18 (Friday)
Luncheon Symposium (inno.N)
| Date & Time | March 18 (Friday), 12:00-13:00 | |
|---|---|---|
| Chair | Dong Ho Lee (Seoul National University, Korea) | |
| Speaker | Tegoprazan, the novel advance in the management of upper gastrointestinal disease Yong Hwan Kwon (Kyungpook National University, Korea) |
|
Sponsored Symposium 1 (Daewoong Pharmaceutical)
| Date & Time | March 18 (Friday), 14:20-15:00 | |
|---|---|---|
| Chair | Byung Chul Yoon (Hanyang University, Korea) | |
| Speaker | Fexuprazan, the new wave of GI treatment Gwang Ha Kim (Pusan National University, Korea) |
|
Sponsored Forum 1 (Otsuka Pharmaceutical Co., Ltd.)
| Date & Time | March 18 (Friday), 17:00-18:00 | ||
|---|---|---|---|
| Chairs | Hyungkil Kim (Inha University, Korea) Sam Ryong Jee (Inje University, Korea) |
||
| Speakers | 17:00-17:15 | Treatment of H. Pylori infected patients with the use of rebamipide Melchor M. Chan (University of Santo Tomas Hospital, Philippines) |
|
| 17:15-17:30 | Benefit of rebamipide for current treatment of Gastroenteropathy due to NSAID or Aspirin Virly Nanda Muzellina (Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Indonesia) |
||
| 17:30-17:45 | Optimal management for upper GI tract with Mucosta SR® 150mg Hang-Lak Lee (Hanyang University, Korea) |
||
| 17:45-18:00 | New paradigm shift & post treatment follow-up of H. Pylori infection Ahn Ji Yong (University of Ulsan, Korea) |
||
Sponsored Forum 2 (YUHAN)
| Date & Time | March 19 (Saturday), 08:00 - 08:30 | |
|---|---|---|
| Chair | Sang-Yong Seol (Inje University, Korea) | |
| Speaker | Commitment to patient compliance: Recomid SR tab (Rebamipide 150mg) Jeong Hwan Kim (Konkuk University, Korea) |
|
Sponsored Symposium 2 (JEIL PHARMACEUTICAL CO.,LTD)
| Date & Time | March 19 (Saturday), 13:30 - 14:20 | |
|---|---|---|
| Chair | Jong-Jae Park (Korea University, Korea) | |
| Speaker | Treatment option for refractory GERD; Focused on dexlansoprazole DR and tianeptine Byung-Wook Kim (The Catholic University of Korea, Korea) |
|